Ruhvenile Biomedical Opc Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth 343.85%
- Profit Growth 36.63%
- Ebitda 38.00%
- Net Worth -104.31%
- Total Assets 53.88%
About Ruhvenile Biomedical Opc
Ruhvenile Biomedical Opc Private Limited (RBOPL) is a registered startup operating as a Company incorporated in India on 12 May 2015 (Nine years and nine months 18 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rajkumar Halder serves as a director at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85190DL2015OPC279996
- Company No.
279996
- Incorporation Date
12 May 2015
- Date of AGM
-
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Healthcare
What products or services does Ruhvenile Biomedical Opc Private Limited offer?
Ruhvenile Biomedical Opc Private Limited offers a wide range of products and services, including Industrial Chemicals & Supplies, Disinfectant Chemicals, Paints, Wall Putty & Varnishes, Interior Paint.
Who are the key members and board of directors at Ruhvenile Biomedical Opc?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajkumar Halder  | Director | 12-May-2015 | Current |
Financial Performance of Ruhvenile Biomedical Opc.
Ruhvenile Biomedical Opc Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 343.85% increase. The company also saw a substantial improvement in profitability, with a 36.63% increase in profit. The company's net worth observed a substantial decline by a decrease of 104.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ruhvenile Biomedical Opc?
Unlock access to Ruhvenile Biomedical Opc's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ruhvenile Biomedical Opc?
Unlock and access historical data on people associated with Ruhvenile Biomedical Opc, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ruhvenile Biomedical Opc, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruhvenile Biomedical Opc's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.